OTC Weight Loss Pills for PCOS: Only One Is FDA-Approved

Is Any Over-the-Counter Weight-Loss Pill Actually FDA-Approved?

Exactly one ingredient sold into this search has FDA approval as a drug: orlistat, available without a prescription as Alli at a 60 mg dose, and by prescription at a higher 120 mg dose as Xenical. Everything else on a shelf marketed for PCOS weight loss — caffeine and stimulant blends, garcinia cambogia, green tea extract, glucomannan, raspberry ketone — is sold as a dietary supplement under US law, which means no federal agency confirmed it works or verified that the bottle contains what the label says before it reached a shelf. That distinction, drug versus supplement, is the entire reason this article exists as a rejection of most of what shows up when you search for this: one ingredient has gone through drug-level testing and regulation, and the rest have not.

That gap matters: a drug’s manufacturer must show a regulator the product works and disclose what’s inside before selling it. A supplement’s manufacturer does neither — the FDA can only act after a product is already on the market and already causing harm, which the next section shows happens often.

Do OTC Weight-Loss Supplements Contain What’s on the Label?

Six of nine previously recalled weight-loss supplements still contained a banned pharmaceutical drug when researchers repurchased and retested them months later — a direct test of 27 recalled products across weight-loss, sexual-enhancement and sports categories found two-thirds still adulterated overall. That is a small sample, but a far larger analysis backs the same finding at scale: a review of every FDA warning for an adulterated dietary supplement from 2007 through 2016 identified 776 adulterated products across 146 companies, of which 317 were marketed for weight loss — and sibutramine turned up in 269 of those 317, or 84.9%.

Sibutramine is not a supplement ingredient. It was a prescription appetite suppressant, withdrawn from the US market entirely in 2010 after a six-year trial of 9,804 adults aged 55 and older with existing cardiovascular disease or type 2 diabetes found sibutramine raised the risk of nonfatal heart attack by 28% and nonfatal stroke by 36% against placebo, with no corresponding drop in cardiovascular death. That trial’s population was older and already at cardiovascular risk — not a PCOS population — but it is the exact reason the drug was pulled from every legal weight-loss product in the country, and it is still the single most common ingredient the FDA finds hiding in supplements marketed for weight loss more than a decade later.

Does Orlistat (Alli) Work for PCOS Specifically?

One small trial is the entire PCOS-specific evidence base for orlistat. Twenty-one women with PCOS — mean age 27, mean BMI 36.7 — completed an 8-week diet run-in, then were randomized to either metformin or orlistat for three months. In that trial, orlistat produced a 4.69% reduction in body weight against metformin’s 1.02%, and both drugs produced a similar reduction in total testosterone. Neither treatment moved fasting insulin, HOMA-IR, SHBG, or lipid levels significantly in this small group. That is a real, PCOS-specific finding — and it is also 21 women in one open-label trial with no placebo arm, not a basis for expecting the same result reliably.

Orlistat works mechanically, not metabolically: it blocks pancreatic and gastric lipases from digesting a portion of dietary fat, so that fat passes through undigested rather than absorbed. That mechanism is also the source of its most reported side effects — oily spotting, gas with discharge, and fecal urgency, especially after a higher-fat meal — and it reduces absorption of the fat-soluble vitamins A, D, E and K along with beta-carotene, which is why the product’s own label recommends a daily multivitamin taken at a different time from the dose. A rarer but documented harm goes further than digestive discomfort: a case report described two patients who developed kidney failure from oxalate crystal deposits while taking orlistat, with partial kidney function recovery after stopping it — the mechanism is that fat left undigested in the gut binds calcium that would normally bind oxalate instead, so more oxalate gets absorbed and eventually deposits in the kidneys. Two patients is not a population-level risk estimate, but the case authors argued the mechanism means every person taking orlistat carries some of this risk, not just the two described.

You may see PCOS increasingly written as polyendocrine metabolic ovarian syndrome (PMOS), after a May 2026 global consensus of more than 50 organisations renamed the condition. Same condition, same mechanism — this article uses PCOS because that is still what most readers search.

Do Caffeine and Stimulant Blends Cause Weight Loss?

Across 18 controlled trials, synephrine — the stimulant most OTC “fat burner” and thermogenic blends build around, usually under the label “bitter orange” or Citrus aurantium — produced no statistically significant weight loss with prolonged use, while measurably raising blood pressure. A systematic review and meta-analysis of placebo-controlled human trials found systolic blood pressure rose by 6.37 mmHg and diastolic by 4.33 mmHg after prolonged synephrine use, with no significant effect on body weight or body composition. These trials were run in general adult populations, not PCOS specifically, but a blood-pressure effect of that size matters for anyone regardless of the underlying condition, and PCOS carries its own elevated cardiometabolic risk independent of any supplement on top of it.

Synephrine is almost never sold alone — it is typically stacked with caffeine to amplify the stimulant effect, and the two ingredients interact. A meta-analysis of green tea catechins found the weight-loss effect itself shrinks under high habitual caffeine intake: pooled across 11 trials, catechins produced 1.31 kg more weight loss than placebo overall, but that effect dropped to a non-significant 0.27 kg in people with habitual caffeine intake above 300 mg per day, against 1.60 kg in people with lower habitual intake — precisely the exposure level a stacked caffeine-plus-stimulant product both contains and normalizes.

Does Garcinia Cambogia Cause Weight Loss?

A meta-analysis of 9 randomized trials found garcinia extract, standardized to its active compound hydroxycitric acid (HCA), produced a real but clinically tiny difference from placebo: 0.88 kg more weight loss (95% CI −1.75 to −0.00), with gastrointestinal adverse events roughly twice as common in the HCA group in the largest included trial. Statistically significant and clinically negligible are both true here at once — the review’s own authors describe the clinical relevance of that effect size as uncertain. The trials pooled were short-term, in general overweight and obese adult populations, and none targeted PCOS specifically or measured androgens, insulin sensitivity, or any of the mechanisms this site’s readers are usually trying to move.

Does Green Tea Extract Help, and What Is the Liver Risk?

A 2015 pharmacovigilance review identified 19 published cases of liver injury linked to green-tea-containing supplements, and the pattern is worth knowing in plain language rather than as a diagnosis code. In that review, 16 of 19 cases occurred in women, the liver damage was classified as hepatocellular in 16 of 19 cases, and reactions to preparations containing green tea alone had an average latency of 179 days before symptoms appeared — meaning the injury can build quietly for months before it becomes noticeable, which is exactly what makes it easy to miss or misattribute to something else. Every case resolved after stopping the product, though four of the cases involving multi-ingredient blends were severe enough to require a liver transplant.

Do Glucomannan or Raspberry Ketone Have Trial Evidence?

Neither has evidence that clears the bar the ingredients marketed alongside them claim. A meta-analysis of 8 randomized trials in overweight and obese adults found glucomannan produced a non-statistically-significant 0.22 kg difference from placebo (95% CI −0.62 to 0.19), with abdominal discomfort, diarrhea and constipation as the reported side effects — a fiber supplement that, on the best available pooled evidence, does not reliably move the scale. Raspberry ketone has even less behind it: no published randomized controlled trial has tested it for weight loss in humans at all. Its popularity traces to rodent and cell-culture research and a wave of media coverage around 2012, not to clinical evidence, and no human safety data exists at the doses sold in weight-loss blends either.

Does Anything Here Interact With Metformin or Other PCOS Medications?

No trial has tested any of these ingredients combined with metformin in a PCOS population, so the concerns below are mechanism-based reasoning, not trial-confirmed interactions — worth knowing either way. Stimulant blends raise heart rate and can produce racing heart, sweating, and jitteriness that feel almost identical to the early symptoms of low blood sugar. If you’re on metformin, inositol, or another glucose-affecting therapy and also taking a caffeine-and-synephrine product, that overlap makes it genuinely harder to tell a stimulant reaction from true hypoglycemia by symptoms alone — checking blood glucose directly, where that’s possible, is more reliable than guessing from how the symptoms feel. Orlistat’s fat-absorption-blocking mechanism can also interfere with other oral medications taken around the same time — a case report described a woman on thyroid-hormone replacement who became clinically hypothyroid after starting orlistat, with the case authors attributing it to reduced thyroxine absorption. One case is not a population rate, but the mechanism is plausible enough that the standard precaution is separating orlistat from any other oral medication dose by a few hours, in whichever direction your prescriber advises for that specific drug.

Who Should Not Take Any of These?

Pregnancy and breastfeeding rule out every ingredient here — none has safety data for either state. Existing cardiovascular disease or uncontrolled blood pressure rules out stimulant blends, given the blood-pressure effect documented above. Existing liver disease rules out green tea extract, and existing kidney disease or a history of kidney stones rules out orlistat, given the mechanisms described in each section above. This is not a complete label warning — it’s the pattern the evidence above actually points to.

None of these ingredients touch the two mechanisms most PCOS treatment is actually built around: insulin resistance and elevated androgens. Orlistat’s one PCOS trial found a testosterone reduction similar to metformin’s, likely a downstream effect of the weight loss itself rather than a direct hormonal action — but insulin sensitivity did not move in that same trial. If insulin resistance is the mechanism you’re trying to address rather than appetite or fat absorption, what actually moves that marker is a different — and better evidenced — starting point than anything reviewed on this page.

Your Next Step

If you’re on this page because diet and exercise changes haven’t moved the number as expected, that frustration is real — PCOS insulin resistance makes weight loss mechanically harder before anything else changes. The options with actual PCOS trial data behind them are prescription GLP-1 drugs, the naltrexone-bupropion combination, and the approaches in the weight-loss guide, both part of this site’s broader weight-loss coverage, not the ingredients reviewed here. If you’re still weighing a supplement despite everything above, check it against how to verify a supplement before you buy it first, and see the full supplements guide for what actually has trial evidence behind it.